Han Jiahuai, Sun Peiqing
Key Laboratory of Ministry of Education for Cell Biology and Tumor Cell Engineering, School of Life Sciences, Xiamen University, Xiamen 361005, China.
Trends Biochem Sci. 2007 Aug;32(8):364-71. doi: 10.1016/j.tibs.2007.06.007. Epub 2007 Jul 10.
Besides its well-known functions in inflammation and other stresses, the p38 mitogen-activated protein kinase pathway also negatively regulates cell proliferation and tumorigenesis. Inactivation of the p38 pathway enhances cellular transformation and renders mice prone to tumor development with concurrent disruption of the induction of senescence. Conversely, persistent activation of p38 inhibits tumorigenesis. Mechanistic insights into this additional p38 function are starting to emerge. For example, p38 has been shown to have a crucial role in oncogene-induced senescence, replicative senescence, DNA-damage responses and contact-inhibition. In addition, the role of the p38 pathway in proliferative control and tumor suppression is mediated by its impact on several cell-cycle regulators. These findings reveal a tumor-suppressing function of the p38 pathway, and indicate that components of the p38 pathway are potential targets for novel cancer therapies.
除了在炎症和其他应激反应中广为人知的功能外,p38丝裂原活化蛋白激酶途径还对细胞增殖和肿瘤发生起负调控作用。p38途径的失活会增强细胞转化,并使小鼠易于发生肿瘤,同时衰老诱导也会受到破坏。相反,p38的持续激活会抑制肿瘤发生。对p38这一额外功能的机制性认识正开始显现。例如,p38已被证明在癌基因诱导的衰老、复制性衰老、DNA损伤反应和接触抑制中起关键作用。此外,p38途径在增殖控制和肿瘤抑制中的作用是通过其对几种细胞周期调节因子的影响来介导的。这些发现揭示了p38途径的肿瘤抑制功能,并表明p38途径的组成部分是新型癌症治疗的潜在靶点。